Stella-Jones (OTCMKTS:STLJF) Shares Down 2.9% – What’s Next?

Stella-Jones Inc. (OTCMKTS:STLJF) shares dropped 2.9% on Monday . The stock traded as low as $56.24 and last traded at $56.3325. Approximately 14,264 shares were traded during mid-day trading, an increase of 127% from the average session volume of 6,291 shares. The stock had previously closed at $58.00.

Analyst Upgrades and Downgrades

Separately, Desjardins reissued a “buy” rating on shares of Stella-Jones in a research report on Thursday, May 7th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, Stella-Jones has an average rating of “Buy”.

Stella-Jones Price Performance

The business has a 50-day moving average price of $57.03 and a two-hundred day moving average price of $63.08. The company has a quick ratio of 1.11, a current ratio of 4.96 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $3.07 billion and a price-to-earnings ratio of 38.32.

Stella-Jones (OTCMKTS:STLJF) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.84 by ($0.02). The business had revenue of $568.67 million during the quarter, compared to analyst estimates of $583.30 million. Stella-Jones had a net margin of 8.66% and a return on equity of 14.92%.

About Stella-Jones

Stella-Jones Inc is a North American producer and distributor of pressure-treated wood products used in infrastructure, utility and residential applications. The company’s core offerings include treated railroad ties, utility poles, crossarms, landscape timbers and posts designed to withstand environmental stresses and extend service life. These products support a range of end markets from railways and power transmission to fencing and outdoor construction.

Founded in 1970 and headquartered in Montreal, Canada, Stella-Jones has grown through both organic expansion and targeted acquisitions to establish a network of manufacturing and treatment facilities across Canada and the United States.